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From a critical review of the evidence on the cholinergic anti-inflammatory pathway and its mode of action, the following conclusions were reached. 
1) Both local and systemic inflammation may be suppressed by electrical stimulation of the peripheral cut end of either vagus.
2) The spleen mediates most of the systemic inflammatory response (measured by TNF α production) to systemic endotoxin, and is also the site where that response is suppressed by vagal stimulation.
3) The anti-inflammatory effect of vagal stimulation depends on the presence of noradrenaline-containing nerve terminals in the spleen.
4) There is no disynaptic connection from the vagus to the spleen via the splenic sympathetic nerve: vagal stimulation does not drive action potentials in the splenic nerve. 
5) Acetylcholine-synthesizing T lymphocytes provide an essential non-neural link in the antiinflammatory pathway from vagus to spleen.
6) Alpha-7 subunit-containing nicotinic receptors are essential for the vagal antiinflammatory action: their critical location is uncertain, but is suggested here to be on splenic sympathetic nerve terminals.  




The concept of the cholinergic anti-inflammatory pathway dates back to investigations on the anti-inflammatory actions of a drug (CNI-1493). This agent was shown to suppress the inflammatory response in the rat’s paw after local injection of the irritant, carageenin  ADDIN EN.CITE (). The anti-inflammatory action of the drug was found to be indirect, via the brain, because it was effective at far lower intracerebroventricular (ICV) doses compared with those given systemically. Its anti-inflammatory action was prevented by cutting the vagi. Strikingly, the anti inflammatory action of the drug could be mimicked by electrical stimulation of the vagi  ADDIN EN.CITE (). Next, the anti-inflammatory actions of CNI-1493 and of electrical stimulation of the vagus were tested in the context of systemic inflammation, produced by high doses of intravenous lipopolysaccharide (LPS)  ADDIN EN.CITE (, ). The inflammatory response was most commonly assessed by measurements of tumour necrosis factor alpha (TNFα), a necessary and sufficient mediator of inflammation  ADDIN EN.CITE (, ). Most subsequent evidence on the cholinergic antiinflammatory pathway comes from studies using this paradigm, and that evidence will be the focus of the present critical review. 
Borovikova and colleagues  demonstrated that either giving CNI-1493 or stimulating the peripheral end of either vagus was effective in lessening the systemic inflammatory response in rats injected with high doses of intravenous LPS derived from E.coli (15 mg/kg, the LD50)  ADDIN EN.CITE (, ). Both stimuli were found to suppress the production of inflammatory cytokines such as TNFα in liver and spleen, and to reduce their circulating levels  ADDIN EN.CITE (, ). Here, too, the action of CNI-1493 was prevented by cutting the vagi. Although the anti-inflammatory action of CNI-1493 could be blocked by atropine  ADDIN EN.CITE (), later experiments showed that the effect of vagal stimulation could not be blocked by a muscarinic antagonist (atropine methyl nitrate)  ADDIN EN.CITE (). These findings were interpreted as showing a central but not a peripheral muscarinic link in the vagal anti-inflammatory pathway and, indeed, centrally acting muscarinic agonists were shown to suppress inflammation in a manner that depended on the integrity of the vagi  ADDIN EN.CITE (). Interestingly, an alternative explanation was not investigated: that electrical stimulation of the peripheral end of the cut vagus might act by a mechanism distinct from that caused by CNI-1493 or central muscarinic agonists. Electrical stimulation would have activated not only preganglionic efferent fibres but also antidromically driven vagal afferent fibres (over 80% of the vagus is afferent), perhaps explaining why the peripheral action is not blocked by muscarinic antagonists.   
An essential nicotinic link in the peripheral pathway was then demonstrated by the finding that while the anti-inflammatory action of vagal stimulation works in wild-type mice, it does not work in mice that lack the α7 nicotinic receptor subunit  ADDIN EN.CITE (, ). Wang and colleagues inferred that the critical nicotinic receptor was on macrophages, because in vitro studies found that nicotinic agonists suppressed the TNFα production by macrophages of wild-type mice but not those from α7 knockout mice. 
Because of the involvement of the vagus and cholinergic receptors, these mechanisms were termed the ‘Cholinergic antiinflammatory pathway’  ADDIN EN.CITE (, ).  

Developments: involvement of the spleen and the splenic nerves.
	In 2006 the spleen was demonstrated to be essential for the inhibition of systemic inflammation by vagal stimulation  ADDIN EN.CITE (, ). However, these workers also found that removing the spleen itself lowered the production and plasma levels of inflammatory cytokines to the same degree as did vagal stimulation when the spleen was intact. The spleen thus plays a dual role: 1) it is responsible for most of the production of inflammatory cytokines in response to intravenous LPS, and 2) it is the site where that production is suppressed by vagal stimulation. 
The initial formulation of the cholinergic anti-inflammatory pathway postulated that the action of vagal efferent neurons was exerted directly on macrophages (Fig 1 A, ()). The discovery of the central importance of the spleen  ADDIN EN.CITE () necessitated a modification of this plan, because of evidence that the rodent spleen receives little or no direct (cholinergic) innervation from the vagus, only noradrenergic fibres from the splenic sympathetic nerves  ADDIN EN.CITE (, ). While not all workers agree on this point (), a recent study using an efficient transgenic label for cholinergic structures in mice confirmed that cholinergic innervation of the spleen was sparse (). 
To account for the vagal signal reaching the spleen, a disynaptic connection was postulated  ADDIN EN.CITE (). Preganglionic parasympathetic fibres in the vagus were proposed to synapse with postganglionic sympathetic neurons in the celiac ganglion: those postganglionic sympathetic neurons were then proposed to travel in the splenic nerves to innervate the spleen (Fig 1 B). This postulated disynaptic pathway has been presented in numerous review articles from several sources  ADDIN EN.CITE (, , , ). Evidence used in support of this model includes the finding that some vagal preganglionic neurons innervate the celiac ganglion, a sympathetic ganglion (), from which postganglionic sympathetic neurons could emerge to form the splenic nerves and innervate the spleen. Further support was taken from the finding that the splenic sympathetic nerves are necessary for the anti-inflammatory action of vagal stimulation  ADDIN EN.CITE (, ). The vagal antiinflammatory action was not present in animals whose spleens were surgically denervated a week before the test, so that its sympathetic innervation had degenerated. Depletion of noradrenaline by reserpine treatment also prevented the anti-inflammatory action of vagal stimulation  ADDIN EN.CITE (). 
It may be noted that this model substitutes adrenergic for cholinergic signalling to macrophages as the final link that suppresses their production of TNFα. Splenic macrophages express both nicotinic and beta adrenergic receptors, however, and both  have been shown in vitro to suppress TNFα production  ADDIN EN.CITE (, , ).

A spanner in the works: no disynaptic pathway from vagus to spleen
	The central role of the spleen in the systemic inflammatory response is clear, as is the finding that its sympathetic innervation is necessary for the anti-inflammatory response to vagal stimulation. We recently tested the idea that there is a disynaptic link from the vagus to the splenic nerve (). Anatomically, we found that the large majority of splenic-projecting sympathetic neurons were located in the suprarenal rather than the celiac ganglia, and that vagal efferent terminals made no synaptic contact with them. Functionally, we showed that electrical stimuli delivered to the peripheral end of the cut vagus, using the same parameters that were previously shown to inhibit inflammation, did not drive action potentials in the splenic nerve (). Together, these findings make it clear that the model showing a disynaptic vagal connection to the spleen (Fig 1 B, C) cannot be correct. 

Resolution
	How can these apparently contradictory findings be reconciled? The splenic nerves are essential for the vagal action on inflammation, yet that role is not played by relaying action potentials from vagus to spleen. Fortunately some clues in the literature suggest a relevant mechanism. In another inflammatory model, Miao, Jänig & Levine () found that synovial plasma extravasation in response to bradykinin depended critically on the presence of sympathetic nerve terminals, but not on their action potentials. Acutely abolishing the activity of these sympathetic nerves by decentralization or locally applied tetrodotoxin had no effect. However, cutting the nerves several days before the experiment was effective. The latter allowed the nerve terminals to degenerate. An action of the sympathetic nerve terminals that did not require action potentials was the logical conclusion. Now, in the case of the spleen, only chronic denervation has been tested for its effect on the anti-inflammatory action of vagal stimulation  ADDIN EN.CITE (). This allows the terminals to degenerate. Reserpine treatment, which also blocks the vagal action, depeletes terminals of noradrenaline. We predict that the presence of noradrenaline-containing terminals in the spleen will be sufficient to mediate the vagal anti-inflammatory action, independently of any action potentials in the splenic nerve. That prediction (Fig 1 D) remains to be tested.
	The issue of how the influence of vagal stimulation reaches the spleen will be addressed below.

Recent developments.
	In 2011, Rosas-Ballina and colleagues found that the acetylcholine necessary for the ‘cholinergic anti-inflammatory pathway’, activated by vagal stimulation, was not neural in origin. In a series of elegant experiments these workers found that a subset of T-lymphocytes synthesize acetylcholine, and these are present in the spleens of mice  ADDIN EN.CITE () ().  Without these T-cells (in nude mice, who lack functional T-cells), vagal stimulation had no anti-inflammatory effect. But that effect could be at least partly restored to nude mice by the adoptive transfer of acetylcholine-synthesizing T lymphocytes into these animals  ADDIN EN.CITE (). 
The non-neural origin of acetylcholine in the spleen explains at least one conundrum. Neurally released acetylcholine is hydrolysed extremely rapidly by cholinesterases. Only a continuing source of production, such as provided by these T-cells, could explain why acetylcholine levels in the spleen continue to rise over 15 minutes after the cessation of nerve stimulation (see Rosas-Ballina et al., 2011, figure 1). It also provides a likely mechanism for non-neural communication from the vagus to the spleen.

Vagal communication to the spleen – the non-neural link
The evidence above makes any direct neural link from the vagus to the spleen highly unlikely, so we now need to consider non-neural channels of communication. The mechanism is presently unknown, but cellular migration is an attractive possibility. Lymphocytes circulate, and the spleen sequesters a proportion of these circulating cells (). Its ability to do so is enhanced during systemic inflammation  ADDIN EN.CITE (). The vagus, though it does not innervate the spleen, provides extensive innervation to the gastrointestinal tract, where there are substantial depots of secondary lymphoid tissue (). Indeed, there is substantial innervation by postganglionic enteric neurons associated with immune cells in the lymphoid tissue of the gut ().  We postulate that stimulating vagal efferent fibres, and/or antidromically activating vagal afferent fibres, somehow stimulates one or more of these depots into mobilizing lymphocytes, including acetylcholine-synthesizing T-cells. Once mobilized, a proportion of these would be sequestered by in the spleen. We are unaware of any direct evidence that vagal stimulation mobilizes cells from the gastrointestinal tract, but it seems plausible in the light of evidence that it can mobilize lymphocytes from the thymus (). 
	These proposals are shown schematically in Figure 1 D. The relevant evidence is summarised below.

Summary of salient evidence on the cholinergic anti-inflammatory pathway in vivo.

1)	CNI-1493 acts via the brain to inhibit local and systemic inflammation. The action on local inflammation is prevented by cutting the vagi. 
2)	Muscarinic agonists, when applied ICV also suppress systemic inflammation. Cutting the vagi blocks this effect but a peripherally acting muscarinic antagonist, atropine methyl nitrate, does not. 

These findings show that the vagus is an essential efferent pathway for the central actions of these drugs to suppress inflammation. 

3)	Electrical stimulation of the peripheral end of the cut cervical vagus suppresses local and systemic inflammation. 
4)	The anti-inflammatory action of stimulating the peripheral end of the cut vagus does not work in mice lacking the α7 nicotinic receptor subunit. 
5)	Nor does the anti-inflammatory action of vagal stimulation work in nude mice, who lack T lymphocytes. Adoptive transfer of ACh-synthesizing T lymphocytes into nude mice restores some vagal anti-inflammatory action.

This evidence tells us that experimental activation of vagal efferent pathways (and/or perhaps antidromic activation of vagal afferent fibres) gives rise to suppression of inflammation in a manner that depends on nicotinic receptors containing the α7 subunit and on acetylcholine-synthesizing T lymphocytes. The site of the essential nicotinic receptor was not established, though splenic macrophages  ADDIN EN.CITE () and sympathetic ganglion cells  ADDIN EN.CITE () have both been suggested. The cholinergic link appears to be non-neural in origin. 

6)	Removal of the spleen substantially reduces the plasma TNFα response to systemic LPS (achieving levels similar to those resulting from vagal stimulation in intact animals). Stimulating the vagus after splenectomy lowers the TNFα response no further  ADDIN EN.CITE ().

This indicates that the spleen is the main source of circulating TNFα due to challenge with systemic LPS. Vagal stimulation acts to inhibit that production by the spleen. 

7)	Destruction of the noradrenergic splenic nerves or depletion of terminal noradrenaline content by reserpine blocks the anti-inflammatory action of vagal stimulation  ADDIN EN.CITE ().

This demonstrates that the presence of noradrenaline-containing nerve terminals in the spleen is necessary for the anti-inflammatory action of vagal stimulation. 

8)	There is no disynaptic link from the vagus to the spleen via the splenic nerves. Stimulating the vagus does not drive action potentials in the splenic nerves (). 
9)	Direct stimulation of the splenic nerves suppresses systemic inflammation even in mice lacking the α7 nicotinic receptor subunit  ADDIN EN.CITE () (when vagal stimulation does not work).

These findings indicate that vagal stimulation acts on the spleen by a non-neural pathway. The (non-neural) vagal action on splenic TNFα production in systemic inflammation depends on the presence of noradrenergic sympathetic terminals in the spleen, but evidently not on action potentials from the parent neurons. A suggested mechanism to take account of the above findings is illustrated in Fig 1D. It is testable. As a counterpart, the effectiveness of direct stimulation of the splenic nerves demonstrates that there is a distinct sympathetic antiinflammatory pathway, whose action is mediated by action potentials in the splenic nerves, and does not require the α7 nicotinic receptor subunit.

The Inflammatory Reflex 
	The term ‘Inflammatory Reflex’ was introduced a decade ago by Tracey in an influential review (). It describes a limiting action of the central nervous system (CNS) on inflammation: CNS pathways respond to signals of injury or inflammation, and act reflexly to suppress the inflammatory cascade. That anti-inflammatory action may be on local and/or on systemic inflammation. Most of the evidence has been gathered with respect to systemic inflammation – typically that produced by giving lethal or high sublethal doses of LPS to rodents. The anti-inflammatory action of vagal stimulation has been repeatedly demonstrated in this model  ADDIN EN.CITE (, , , , , , , , ).
	Any reflex can be considered as having an afferent pathway, a central processing component and an efferent pathway. Two other reflex responses to systemic LPS have been well studied: fever and the activation of the hypothalamic-pituitary-adrenal (HPA) axis. Ideas on the role of the vagus as an afferent pathway for these responses have evolved over the years, reflecting successive control for the confounding factors that accompany chronic subdiaphragmatic vagotomy (principally malnutrition). Current opinion  ADDIN EN.CITE (, ), indicates that when confounding factors are accounted for, vagotomy has no effect on responses to LPS, with the possible exception of when minimal doses evoke monophasic fever. When higher doses of LPS are given intravenously, it is clear that the main afferent pathways driving fever and the HPA axis are humoral, and involve prostaglandin E2 as the key mediator acting in the brain  ADDIN EN.CITE (, , , ).  For the inflammatory reflex, the afferent pathways are not well worked out, but it is likely that similar considerations apply.  
	The topic that concerns us here is the efferent pathway of the inflammatory reflex. It has been stated on several occasions that the efferent arm of the inflammatory reflex is the cholinergic anti-inflammatory pathway  ADDIN EN.CITE (, ). If that is so, the stimulus that triggers inflammation (e.g. i.v. LPS) must reflexly activate vagal efferent fibres with an anti-inflammatory action. The critical test of this idea is to cut the vagi, which should then remove that anti-inflammatory action - worsening the inflammation. Does this happen? 
	The original study demonstrating the inhibitory effect of vagal stimulation on systemic inflammation  ADDIN EN.CITE () found that cutting the vagi caused a 40% increase in the plasma TNFα of rats given LPS (15 mg/kg i.v). However, that study also found that the plasma corticosterone levels were 33% lower in vagotomised animals. It is therefore uncertain how much of the enhanced inflammatory response could be attributed to removal of vagal efferents and how much to reduced glucocorticoid restraint on inflammatory processes (). A later study on rats from the same laboratory found that bilateral vagotomy caused a non-significant increase in the plasma TNFα response to 10 mg/kg i.v. LPS  ADDIN EN.CITE (). Finally, a study on rats from another laboratory found that the plasma TNFα response to 8 mg/kg i.v. LPS was significantly decreased (~ 50%) after vagotomy  ADDIN EN.CITE (). In sum, no clear case has been made that the inflammatory response to high doses of i.v. LPS is increased by vagotomy: the evidence is, at best, equivocal. 




Figure 1: The evolution of the Cholinergic antiinflammatory pathway
A: (2002) shows the original formulation, in which vagal efferent fibres are proposed to act directly on immune cells (principally macrophages) to suppress their production of TNFα and other inflammatory mediators ().
	B: (2008) The discovery of the importance of the spleen and the splenic nerves  ADDIN EN.CITE (, ) and the lack of direct vagal innervation of the spleen   ADDIN EN.CITE (, ) prompted this revision. Here, the preganglionic vagal fibres are postulated to synapse with postganglionic splenic (sympathetic) neurons in the celiac ganglion. One suggested site for the essential α7-containing nicotinic receptor  ADDIN EN.CITE () was on the postganglionic splenic neuron  ADDIN EN.CITE (, ).  
	C: (2011). This version incorporates the recognition of the essential role of acetylcholine-synthesizing T-cells. Here, the essential α7-containing nicotinic receptor is placed in the spleen, on splenic macrophages  ADDIN EN.CITE ().
	D: (2013) shows the model proposed here. It recognizes that the link from the vagus to the spleen is non-neural. In this version the essential α7-containing nicotinic receptor is placed not on the cell bodies but on the peripheral terminals of the splenic sympathetic nerves. When stimulated by acetylcholine from incoming T-cells, they release noradrenaline, which then acts on beta adrenergic receptors on splenic macrophages to suppress their production of TNFα. No action potentials are required. 
If, on the other hand, action potentials are generated in the splenic nerve by direct stimulation  ADDIN EN.CITE (), the anti-inflammatory action bypasses the need for α7-containing nicotinic receptors  ADDIN EN.CITE (). 
Abbreviations: ACh, acetylcholine; β, beta adrenergic receptor; ChAT+, Choline acetyl transferase positive, i.e. ACh-synthesizing, T cell; LPS, lipopolysaccharide; N, nicotinic cholinergic receptor; NA, noradrenaline; TNFα, tumour necrosis factor alpha.
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Figure 1: The evolution of the Cholinergic antiinflammatory pathway






